[Anticoagulation by oral treatment with vitamin K antagonists].
A survey is given on pharmacology and indications for the treatment with vitamin K antagonists. The therapeutic handling and self control by the patient is described.
Kemkes-Matthes
B
B
Interdisziplinärer Schwerpunkt für Hämostaseologie des Universitätsklinikums Giessen und Marburg GmbH. Bettina.Kemkes-Matthes@innere.med.uni-giessen.de
D000284:Administration, Oral; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D003374:Coumarins / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D019934:International Normalized Ratio; D009203:Myocardial Infarction / Q000188:drug therapy; D013923:Thromboembolism / Q000517:prevention & control; D014812:Vitamin K / Q000037:antagonists & inhibitors*
D000925:Anticoagulants; D003374:Coumarins; D014812:Vitamin K; C030123:coumarin